2024-01-10 01:48:22
The shock that Grifols has suffered due to the devastating report from Gotham City in which it is accused of manipulating its accounts has been noted in the Zamudio Technology Park, where the headquarters of Progenika Biopharma, the jewel in the Basque crown in biotechnology, is located. of which the Catalan company acquired 100% of the capital. This company employs 76 people, most of them university doctors.
Founded in 2000 by scientists such as Antonio Martínez and Laureano Simón and a group of Basque businessmen, Progenika became a star in the nascent Basque biotechnology sector. The group specializes in tests for genetic diagnosis of diseases as well as response prediction and monitoring of pharmacological therapy. The Basque Government participated in its creation through the Ekarpen company, which it shares with Kutxabank, Lagun Aro and the Provincial Councils.
In 2013 Grifols took control of Progenika with the acquisition of 60% for 37 million euros, an operation that had the approval of the Basque Government “by strengthening the marketing of its innovative product and multiplying the positioning of know-how.” “how Basque in the world”, as the councilor Arantxa Tapia defended at the time. The payment was paid half in cash and half in Grifols shares.
The Catalan multinational expanded its participation in 2016, reaching 89% after paying 25 million, with the same hybrid formula, and from there it reached 100%. When the pandemic broke out, Grifols developed a test at Progenika to detect covid. The company’s accounts, however, took a hit last year. Its turnover stood at 13 million euros, almost 20% less, and it lost 1.3 million.
#Progenika #Basque #biotech #jewel #Grifols #bought